Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results

This study was conducted to investigate the feasibility and survival benefits of combined treatment with radiotherapy and temozolomide (TMZ), which has been covered by the national health insurance in Japanese patients with glioblastoma since September 2006. Between September 2006 and December 2011,...

Descripción completa

Detalles Bibliográficos
Autores principales: Oike, Takahiro, Suzuki, Yoshiyuki, Sugawara, Ken-ichi, Shirai, Katsuyuki, Noda, Shin-ei, Tamaki, Tomoaki, Nagaishi, Masaya, Yokoo, Hideaki, Nakazato, Yoichi, Nakano, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827088/
https://www.ncbi.nlm.nih.gov/pubmed/24265731
http://dx.doi.org/10.1371/journal.pone.0078943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827088/
https://www.ncbi.nlm.nih.gov/pubmed/24265731
http://dx.doi.org/10.1371/journal.pone.0078943

Ejemplares similares